Cargando…

Oxidation of 5-Chloromethylfurfural (CMF) to 2,5-Diformylfuran (DFF)

2,5-Diformylfuran (DFF) is an important biorenewable building block, namely for the manufacture of new polymers that may replace existing materials derived from limited fossil fuel resources. The current reported methods for the preparation of DFF are mainly derived from the oxidation of 5-hydroxyme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vicente, Ana I., Coelho, Jaime A. S., Simeonov, Svilen P., Lazarova, Hristina I., Popova, Margarita D., Afonso, Carlos A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155580/ https://www.ncbi.nlm.nih.gov/pubmed/28230746 http://dx.doi.org/10.3390/molecules22020329

Ejemplares similares

Efficient One-Pot Synthesis of 5-Chloromethylfurfural (CMF) from Carbohydrates in Mild Biphasic Systems
por: Gao, Wenhua, et al.
Publicado: (2013)

Enzymatic conversion reactions of 5-hydroxymethylfurfural (HMF) to bio-based 2,5-diformylfuran (DFF) and 2,5-furandicarboxylic acid (FDCA) with air: mechanisms, pathways and synthesis selectivity
por: Cajnko, Miša Mojca, et al.
Publicado: (2020)

CO(2) Adsorption on Modified Mesoporous Silicas: The Role of the Adsorption Sites
por: Ravutsov, Martin, et al.
Publicado: (2021)

Co-Immobilization of Tri-Enzymes for the Conversion of Hydroxymethylfurfural to 2,5-Diformylfuran
por: Wu, Zhuofu, et al.
Publicado: (2019)

Comment on Gao, W., et al. “Efficient One-Pot Synthesis of 5-Chloromethylfurfural (CMF) from Carbohydrates in Mild Biphasic Systems”, Molecules 2013, 18, 7675-7685
por: Mascal, Mark
Publicado: (2014)

Metal Nitrate Catalysis for Selective Oxidation of 5-Hydroxymethylfurfural into 2,5-Diformylfuran under Oxygen Atmosphere
por: Hong, Mei, et al.
Publicado: (2019)

Selective oxidation of 5-hydroxymethylfurfural into 2,5-diformylfuran over VPO catalysts under atmospheric pressure
por: Lai, Jinhua, et al.
Publicado: (2019)

Superelectrophilic activation of 5-hydroxymethylfurfural and 2,5-diformylfuran: organic synthesis based on biomass-derived products
por: Ryabukhin, Dmitry S, et al.
Publicado: (2016)

Selective Electrocatalytic Oxidation of Biomass‐Derived 5‐Hydroxymethylfurfural to 2,5‐Diformylfuran: from Mechanistic Investigations to Catalyst Recovery
por: Kisszekelyi, Peter, et al.
Publicado: (2020)

Selective Oxidation of 5‐Hydroxymethylfurfural to 2,5‐Diformylfuran by Visible Light‐Driven Photocatalysis over In Situ Substrate‐Sensitized Titania
por: Khan, Ayesha, et al.
Publicado: (2021)

Highly efficient and tunable visible-light-catalytic synthesis of 2,5-diformylfuran using HBr and molecular oxygen
por: Hu, Wenwei, et al.
Publicado: (2021)

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998)

Selective Production of Phenol on Bifunctional, Hierarchical ZSM-5 Zeolites
por: Popova, Margarita, et al.
Publicado: (2021)

Selective Oxidation of 5-(Hydroxymethyl)furfural to DFF Using Water as Solvent and Oxygen as Oxidant with Earth-Crust-Abundant Mixed Oxides
por: Nocito, Francesco, et al.
Publicado: (2018)

Molecular basis of apoptotic DNA fragmentation by DFF40
por: Ha, Hyun Ji, et al.
Publicado: (2022)

Vapor-Phase Hydrogenation of Levulinic Acid to γ-Valerolactone Over Bi-Functional Ni/HZSM-5 Catalyst
por: Popova, Margarita, et al.
Publicado: (2018)

Progress in the Utilization of Coal Fly Ash by Conversion to Zeolites with Green Energy Applications
por: Boycheva, Silviya, et al.
Publicado: (2020)

DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival
por: Banas, Tomasz, et al.
Publicado: (2017)

Photocatalytic Aerobic Oxidation of Biomass-Derived 5-HMF to DFF over MIL-53(Fe)/g-C(3)N(4) Composite
por: Huang, Danyao, et al.
Publicado: (2022)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

CO(2) Adsorption on the N- and P-Modified Mesoporous Silicas
por: Tumurbaatar, Oyundari, et al.
Publicado: (2022)

A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
por: Jodrell, D. I., et al.
Publicado: (1991)

CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
por: De Placido, S., et al.
Publicado: (1995)

CMF, Chaikin money flow: changes anticipating price reversal
por: Thomsett, Michael C
Publicado: (2011)

AO Craniomaxillofacial Surgery (AO CMF): A World of Opportunities
por: Kadam, Dinesh
Publicado: (2020)

The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration
por: Dutsch-Wicherek, Magdalena, et al.
Publicado: (2006)

Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells
por: Martínez-Escardó, Laura, et al.
Publicado: (2021)

A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
por: De Placido, S, et al.
Publicado: (2005)

Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast
por: Harper-Wynne, C, et al.
Publicado: (1999)

A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP
por: Anvari, Kazem, et al.
Publicado: (2015)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
por: Mousavi, Seyyed AsadoLah, et al.
Publicado: (2013)

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
por: Cameron, D A, et al.
Publicado: (2003)

Pentaeuropium dicadmium pentaantimonide oxide, Eu(5)Cd(2)Sb(5)O
por: Saparov, Bayrammurad, et al.
Publicado: (2011)

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
por: Earl, H M, et al.
Publicado: (2012)

Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein
por: Barazesh, Mahdi, et al.
Publicado: (2019)

MiRNA-145 Induces Apoptosis in a Gallbladder Carcinoma Cell Line by Targeting DFF45
por: Yuan, Yuan, et al.
Publicado: (2018)

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?
por: Cameron, D A, et al.
Publicado: (2002)

Solvent-Free Synthesis of 2,5-Bis((dimethylamino)methylene)cyclopentanone
por: S. Martins, Inês, et al.
Publicado: (2019)

Hydrodemethoxylation/Dealkylation on Bifunctional Nanosized Zeolite Beta
por: Popova, Margarita, et al.
Publicado: (2021)

The cell density factor CMF regulates the chemoattractant receptor cAR1 in Dictyostelium
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_5eh2cvtotv2oja681v7726aku9